Christopher Bahl is a molecular engineer using computational design to develop new protein drugs that combat infectious disease.

He is Head of Protein Design at Institute for Protein Innovation (IPI). His team is leveraging the latest advances in computational design to accelerate the creation of new protein-based drugs to treat a wide range of diseases.

Bahl was selected as a 2019 TED Fellow for his pioneering work on the de novo design of novel mini-proteins and constrained peptides, an innovative approach for creating therapeutics with the potential to tackle long-standing challenges in medicine and human health.

Technology, Science, Science and Technology Professionals, Molecular biologist TED, Health, Medicine, Researcher, Research scientist,